WASHINGTON: The US Department of Justice on Thursday (Jul 23) said it will not stand in the way of efforts by companies, including Eli Lilly and Co and Amgen, to share information to help scale up capacity to manufacture antibody treatments for COVID-19. In a letter to Lilly, Amgen, AbCellera ...
from Latest News https://ift.tt/2ZXaZRb
US clears way for drugmakers to share COVID-19 antibody capacity
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment